O4 Detail Hero Banner

Insights for life sciences organizations

Read, watch or listen to these resources to learn how real-world data can help you innovate, grow and improve patients’ lives.

O4 1 Column (Full)
O4 1 Column (Full)
O4 50-50 Content Block
E-book

The power of using integrated data to understand drug performance

These real-world examples show how integrated data can help you improve medication adherence, track patient journeys, evaluate total cost of care and more.

Dig deeper into the evolving role of real-world evidence

Clinicogenomics linked data advances research

Clinicogenomics data can fuel all stages of development.

Four steps to an enterprise data strategy

Maximize data investments.

Is Your Real-World Data Research Ready?

Go behind the scenes of real-world data.

O4 Hubs

Insights

Clinicogenomics: new, linked data is advancing research

Rich, longitudinal clinicogenomics data can fuel all stages of drug development.

Optum Patient Profiles For Life Sciences Video

A more complete view of the patient experience

Forward-thinking strategies for 2022

Explore this video series featuring insights for Life Sciences leaders, delivered by experts from across health care.

New Data Dimensions In Life Sciences Research

Expanded research methods can address cost at the root level.

Sleep treatment across the ages

Combining real-world data and primary research helps us better understand insomnia.

Four steps to an enterprise data strategy

Explore the steps for creating a real-world data strategy that helps life sciences companies to maximize their data investments.

Optum Patient Profiles

Capture a customized picture of the patient.

The unifying power of integrated data

Read how the integration of EHR and claims data can change what we can collectively learn about outcomes.

Dynamic Assessment Of Pregnancies And Infants

We help answer questions about maternal and infant health.

Is Your Real-World Data Research Ready?

Real-world data can help evaluate the effectiveness of medications and therapies, which is why evaluation should be part of the investment.

Curious case of costly complications

How can analytics help tell your cost and outcomes story?

Real-world data fills rare disease data gaps

Data removes the barriers to understanding rare disease.

PMSA Webinar: Avoiding common RWD pitfalls

Optum experts give a snapshot of commonly encountered pitfalls when using RWD and recommendations to help avoid them in this PMSA webinar.

Four steps to a RWD enterprise strategy

Lou Brooks, SVP, Real-World Data and Analytics at Optum

Real Talk on Real-World Evidence: Practical Applications in 2021

Virtual fireside chat with Advisory Board and Optum Life Sciences leaders explores the expanded use and next wave of RWE applications

Real-world data centralized teams

Expanding the use of RWD requires expertise and leadership.

Assisting the FDA with real-world evidence

As seen in Frost & Sullivan's Movers & Shakers series

Take Bold Action & Maximize Impact

Take Bold Action & Maximize Impact

Maximize Clinical Trial Enrollment

Use clinical and claims data to conduct precision patient finding.

Clinicogenomics: The next big leap in real-world data

Optum clinical genomics is positioned to shape a new generation of evidence that accelerates understanding of disease.

Evolving clinical trials from paper to digital

Accelerate research through a digitized model.

Monitoring COVID-19 vaccine safety

Discover insights from Dr. John Seeger’s recent participation at the Duke-Margolis Thirteenth Annual Sentinel Initiative Public Workshop.

Case Study Insights from Patient Journey Mapping

Tracking the health care experience informs decision-making.

Modernizing clinical trials with EHRs

Discover how Optum and three provider organizations leveraged EHR systems to modernize a clinical trial aimed at diabetes treatment.

Demonstrating product value with integrated data

A special webinar hosted by MM&M demonstrates how integrated EHR and claims data offers a new foundation for demonstrating product value.

Understanding Market Shifts

Optum expertise provides competitive insights.

Preparing for the future of life sciences

Life sciences leaders are thinking differently with data to support novel strategies.

Optum, FDA collaborate on vaccine and biologic research

FDA reaches agreement with life sciences segment of Optum to provide data and expertise to evaluate and research biologics and vaccines.

When ‘Is it safe for me?’ changes to ‘Is it safe for us?’

Studying the impact of treatments on pregnancy and infants can help patients, providers and pharmaceutical companies make key decisions.

The Curious Case of the Costly Complication

Optum helps a client prove product effectiveness

Pinpoint asthma, COPD and ACOS with EHR data

Optum study highlights clinical clues in asthma and COPD.

Optum Dynamic Assessment of Pregnancies and Infants

Assess the impact of medication use during pregnancy and the impact on infant health.

Realizing the full potential of clinicogenomics

Join Optum genomics experts as they discuss the progress being made to develop datasets that will aid in drug discovery and development.

Pilot Program Lowers Cardiovascular Disease Risk | Optum

An innovative program involving patient awareness and provider outreach improves patient use of lipid-lowering therapies.

Accelerate drug development with clinicogenomic RWE

Optum, Novartis and GuardantINFORM experts discuss the ever-increasing importance of clinicogenomic data during this Endpoints News webinar.

Watch: OLS Data Leaders at STAT Summit

Break down common missteps when using RWD and create practical strategies to overcome them.

Reflections on PCMA's recent Annual Meeting

Total cost of care and value-based arrangements between manufacturers and payers is top of mind of HEOR and Medical Affairs leaders.

The 11 things life sciences leaders need to know

We identified 11 trends worth watching.

7 Trends Shaping Life Sciences Strategies in 2023

Life sciences market experts from Optum and Advisory Board offer their bold predictions and insights in 2023 for the industry.

Clinicogenomics Enable Precision Drug Development | Optum

Informing the FDA BEST Initiative

As a key FDA collaborator, Optum Epidemiology generates reproducible results that inform regulatory decisions for COVID-19 vaccines.

Building public confidence with health data

See how the FDA and Optum use real-world evidence to monitor the safety and effectiveness of COVID-19 vaccines in our youngest populations.

Are You Maximizing the ROI of Your Real-World Data?

Help your organization capitalize on these vital resources using lessons and tools compiled by the Optum life sciences real-world data team.